Lv1
10 积分 2025-08-12 加入
High-risk neuroblastoma as a model for immunotherapy of non-immunogenic cancers: where might we be in 20 years?
1天前
待确认
Naxitamab-combination Therapy for the Treatment of Patients With Refractory and/or Relapsed High-risk Neuroblastoma
2个月前
已完结
Author Correction: Clonal evolution during metastatic spread in high-risk neuroblastoma
2个月前
已完结
Paediatric Strategy Forum for Medicinal Product Development of Cyclin-Dependent Kinase Inhibitors in Children and Adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug Administration
2个月前
已完结
A phase II trial of Naxitamab plus stepped-up dosing of GM-CSF for patients with high-risk neuroblastoma in first complete remission
2个月前
已完结
皖公网安备34019202002308
